Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int ‐1‐risk MDS patients: Results of the phase II KALLISTO trial

European Journal of Haematology, EarlyView.

Source: European Journal of Haematology - June 22, 2018 Category: Hematology Authors: Norbert Gattermann , Rosa Coll , Lutz Jacobasch , Allameddine Allameddine , Amin Azmon , Laurie DeBonnett , Andreas Bruederle , Jie Jin , on behalf of Source Type: research